Laxmi Organic Industries logo

Laxmi Organic Industries

LXCHEM NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹4,760 Cr
Volatility
Moderate
P/E Ratio
38.67
EBITDA
₹187 Cr
Return on Equity
4%
Debt to Equity
0.27
Book Value
₹71.45
EPS
₹4.21
52W High
₹241
52W Low
₹107.6

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

5
  • The company has delivered a poor sales growth of 9.99% over past five years.
  • Company has a low return on equity of 5.84% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 12.1% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -3.05%

Growth Rate

Revenue Growth
-4.94% lower than 3Y
Net Income Growth
-30.04% lower than 3Y
Cash Flow Change
62% higher than 3Y
ROE
-32.77% lower than 3Y
ROCE
-51.87% higher than 3Y
EBITDA Margin (Avg.)
-35.64% lower than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 44d ago
AI opinion · based on fundamentals
Risk medium

Laxmi Organic Industries trades at a market cap of ₹4,967 Cr with a P/E of 40.2x and P/B of 2.54x. The company posted FY25 revenue of ~₹2,985 Cr (up ~4.2% YoY) with an EBITDA margin of 9.4% and PAT margin of 3.8%, reflecting a modest recovery after a period of profit decline, while its 3-year ROE averages just ~6%.

Bull Case 7
  • FY25 EBITDA grew 9% YoY to ₹2,796 million with EBITDA margin expanding 41 bps to 9.4%, signaling early margin recovery
  • Q3FY25 gross margin improved 240 bps YoY to 33.1%, and 9MFY25 gross margin expanded 320 bps to 34.8%, indicating improved pricing power or cost management
  • TTM profit growth of 25% shows a meaningful rebound from recent years of profit decline (-14% CAGR over 3 years)
  • 10-year compounded sales CAGR of 11% and 10-year profit CAGR of 12% demonstrate a long track record of growth through cycles
  • Debt-free balance sheet (reported 0.00 debt-equity ratio) with an upgraded credit rating of AA/Stable from India Ratings in Jan 2025 provides financial flexibility for expansion
  • Q1FY27 revenue surged 40% YoY to ₹9,683 million with EBITDA up 272% to ₹1,143 million and margins at 11.5%-11.8%, indicating a strong operational turnaround trajectory
  • Promoter holding remains at ~63.4%, reflecting strong promoter commitment despite a 3.05% reduction over three years
Bear Case 8
  • P/E of 40.2x is elevated relative to the chemicals sector average, especially given only 4.2% revenue growth in FY25 and 3.8% PAT margin
  • 3-year ROE averages just ~6% (last year 4%), well below cost of equity, indicating poor capital efficiency
  • 5-year compounded sales growth of only ~10% (screener data shows 9.99%) is modest for a specialty chemicals company trading at premium valuations
  • 3-year compounded profit CAGR is -14% and 5-year profit CAGR is -9%, showing prolonged earnings deterioration
  • Dividend payout has been low at 12.1% of profits over the last 3 years with a yield of just 0.16%, offering minimal income return to shareholders
  • Stock price has declined with 1-year CAGR of -11% and 3-year CAGR of -12%, significantly underperforming broader markets
  • Promoter holding has decreased by 3.05% over the last three years, which may signal reduced insider confidence
  • Company may be capitalizing interest costs, potentially flattering reported profitability and understating true operating expenses

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 42d ago
Positives 3
  • Q1FY27 PAT surges 216% YoY Jul 29

    Net profit jumped 216% YoY to ₹677 Mn in Q1FY27, driven by 40% revenue growth and significant margin expansion across both Essentials and Specialties segments.

  • Q1FY26 profit also surged Jul 29

    Laxmi Organic reported Q1FY26 net profit of ₹633 Mn, reflecting higher revenue and improved operational efficiency, establishing a strong base for continued growth.

  • FY26 revenue and dividend declared Jul 14

    FY26 standalone revenue stood at ₹28,085.32 Mn with net profit of ₹792.58 Mn. Board recommended a final dividend of ₹0.30 per share.

Neutral 2
  • Q1FY27 earnings call hosted Jul 30

    Laxmi Organic held an investor meet on July 30, 2026 at 2:00 PM IST to discuss Q1 FY27 results, led by MD & CEO Dr. Rajan Venkatesh and CFO Amit Jain.

  • BRSR filed for FY26 Jul 14

    Laxmi Organic filed its Business Responsibility & Sustainability Report for FY26, detailing ESG performance, governance practices, and material topics.

TL;DR: Laxmi Organic is delivering strong profit growth with Q1FY27 PAT up 216% YoY to ₹677 Mn on 40% revenue growth and margin expansion in both segments. FY26 full-year revenue crossed ₹28 Bn. No identifiable headwinds in recent news flow. The earnings trajectory is clearly improving, and sustained margin expansion could drive further re-rating if maintained over coming quarters.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
729
652
694
792
718
771
786
710
693
700
719
735
968
Expenses
652
613
642
702
647
697
712
651
662
663
669
682
854
Operating Profit
77
39
52
90
71
75
75
59
31
37
50
54
114
OPM %
11%
6%
8%
11%
10%
10%
10%
8%
4.4%
5%
7%
7%
12%
Other Income
4
8
5
8
12
7
6
1
6
4
3
3
3
Interest
5
2
1
-1
3
8
2
7
5
6
7
5
4
Depreciation
21
28
28
31
26
27
31
40
17
20
20
19
22
PBT
56
18
30
68
54
46
47
13
14
16
26
32
92
Tax %
31%
39%
8%
35%
36%
39%
38%
-64%
-51%
29%
2%
34%
26%
Net Profit
38
11
27
44
34
28
29
22
21
11
25
22
68
EPS in Rs
1.44
0.4
0.99
1.61
1.24
1.02
1.06
0.79
0.77
0.4
0.92
0.78
2.44
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,074
1,047
1,076
1,376
1,569
1,534
1,768
3,084
2,797
2,865
2,985
2,847
3,122
Expenses
988
966
957
1,222
1,414
1,418
1,548
2,713
2,548
2,609
2,699
2,674
2,867
Operating Profit
86
80
119
154
155
117
220
371
248
256
286
172
255
OPM %
8%
8%
11%
11%
10%
8%
12%
12%
9%
9%
10%
6%
8%
Other Income
1
2
2
3
6
30
4
15
12
28
19
14
13
Interest
26
19
11
12
19
17
19
19
15
7
20
22
21
Depreciation
30
29
28
31
44
49
47
49
72
107
124
77
81
PBT
31
34
82
113
98
81
158
318
173
171
161
88
166
Tax %
31%
22%
13%
33%
26%
13%
20%
19%
28%
29%
29%
10%
—
Net Profit
21
27
72
76
72
70
127
256
125
121
114
79
126
EPS in Rs
21.12
26.56
71.5
75.63
14.46
15.57
4.82
9.72
4.7
4.37
4.1
2.86
4.54
Div. Payout %
0%
0%
0%
0%
0%
11%
10%
7%
11%
14%
12%
10%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10
10
10
10
50
45
53
53
53
55
55
55
Reserves
199
225
295
369
400
382
982
1,248
1,359
1,742
1,851
1,930
Borrowings
249
221
104
215
175
159
149
139
406
143
258
543
Other Liabilities
152
176
240
300
389
484
654
825
595
887
880
915
Total Liabilities
610
632
649
895
1,014
1,069
1,838
2,265
2,412
2,827
3,045
3,443
Fixed Assets
226
215
202
293
346
338
325
394
715
879
1,166
1,481
CWIP
25
40
61
30
31
67
148
374
447
444
398
652
Investments
0
0
0
0
0
0
3
5
23
126
148
37
Other Assets
358
377
386
571
637
664
1,361
1,492
1,228
1,378
1,332
1,274
Total Assets
610
632
649
895
1,014
1,069
1,838
2,265
2,412
2,827
3,045
3,443
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
80
150
-7
188
196
106
46
199
561
108
175
Investing
—
-21
-37
-85
-123
-56
-641
95
-384
-490
-268
-404
Financing
—
-57
-107
85
-63
-123
527
-124
232
-42
90
247
Net Cash Flow
—
1
6
-7
2
16
-7
16
47
30
-70
18
Free Cash Flow
—
53
114
-95
90
118
-10
-243
-277
314
-286
-427
CFO/OP
—
90
113
13
139
181
60
27
100
234
47
107
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
64
67
79
86
76
86
90
79
74
74
66
67
Inventory Days
37
57
37
55
57
51
63
65
58
54
71
70
Days Payable
52
67
85
81
105
138
148
123
92
145
131
140
Cash Conversion Cycle
49
56
30
60
28
-1
5
21
41
-16
6
-3
Working Capital Days
65
66
36
28
28
17
-1
42
31
19
12
31
ROCE %
—
12%
22%
25%
19%
12%
20%
26%
11%
9%
9%
5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Laxmi Organic Industries insights

62 extracted metrics + investor summaries across FY10–FY27.

Log in — free

Shareholding Pattern

FIIs0.69%Promot.69.34%Others3.55%DIIs3.83%Public22.60%As ofJun 2026

Documents

Frequently Asked Questions about Laxmi Organic Industries

What does Laxmi Organic Industries Ltd do?
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired b...
Where is Laxmi Organic Industries Ltd (LXCHEM) listed?
Laxmi Organic Industries Ltd trades as LXCHEM on the NSE and under code 543277 on the BSE.
Which sector does Laxmi Organic Industries Ltd belong to?
Laxmi Organic Industries Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Laxmi Organic Industries Ltd?
Laxmi Organic Industries Ltd has a market capitalisation of ₹4,760 Cr, which places it in the Small Cap band.
What is the PE ratio of Laxmi Organic Industries Ltd?
Laxmi Organic Industries Ltd trades at a PE ratio of 38.67, on earnings per share of ₹4.21, against a book value of ₹71.45 per share.
What is the 52-week high and low of Laxmi Organic Industries Ltd?
Over the last 52 weeks Laxmi Organic Industries Ltd has traded between ₹107.6 and ₹241.
Does Laxmi Organic Industries Ltd pay dividends?
Laxmi Organic Industries Ltd has a dividend yield of 0.18%.
What is the Return on Equity (ROE) of Laxmi Organic Industries Ltd?
Laxmi Organic Industries Ltd reported a return on equity of 4.00%. Its debt-to-equity ratio is 0.27.

Company Information

Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited. The company’s business operations are carried in over 30 countries including 11 offices located in India

Website laxmi.com
Listed 2021-03-25
Face Value ₹ 2
Issued Size 27,71,47,873

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/LXCHEM.md for Laxmi Organic Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List